Rectal Polyp

A rectal polyp is a benign, polypoid growth arising from the mucosal or submucosal layer of the rectum, typically protruding into the lumen. In veterinary medicine, rectal polyps are most commonly epithelial in origin, often classified as adenomatous polyps (adenomas) or inflammatory polyps. They are distinct from malignant neoplasms such as adenocarcinoma, though some adenomas may undergo malignant transformation. Rectal polyps are a significant cause of tenesmus, hematochezia, and dyschezia in dogs and, less commonly, cats. They can be solitary or multiple, sessile or pedunculated, and may vary in size from a few millimeters to several centimeters. The clinical importance lies in their potential to cause chronic lower gastrointestinal signs and their differential diagnosis from more serious conditions like colorectal cancer.

The exact etiology of rectal polyps in dogs and cats is not fully understood, but several factors are implicated. Chronic inflammation of the colorectal mucosa is a major predisposing factor, leading to mucosal hyperplasia and polyp formation. Inflammatory bowel disease (IBD), chronic colitis, and parasitic infections (e.g., Trichuris vulpis) can cause chronic mucosal irritation. Genetic mutations, particularly in the adenomatous polyposis coli (APC) gene and K-ras oncogene, have been identified in human colorectal polyps and are suspected in animals. Viral etiologies, such as papillomavirus, have been associated with squamous papillomas, but not typically with adenomatous polyps. Dietary factors, including low fiber and high fat diets, may contribute to altered gut microbiota and increased risk. Environmental toxins and carcinogens may also play a role. In some cases, no underlying cause is identified, and polyps are considered idiopathic.

Rectal polyps are most commonly diagnosed in middle-aged to older dogs, with a median age of 8-10 years. There is no strong sex predilection, though some studies suggest a slight male predominance. Certain breeds appear to be overrepresented, including Boxers, Collies, German Shepherds, and Poodles, possibly due to genetic predisposition. Cats are less commonly affected, but when present, they are often older (median age 10-12 years). The condition is seen worldwide with no geographic predilection. Incidence rates are not well established, but polyps are among the most common benign colorectal tumors in dogs. In a study of canine colorectal tumors, adenomas accounted for approximately 20-30% of all colorectal neoplasms. The prevalence may be higher in populations with chronic colitis or parasitic infections.

The pathophysiology of rectal polyps involves dysregulation of epithelial cell proliferation and apoptosis. Chronic inflammation leads to increased production of pro-inflammatory cytokines (e.g., TNF-α, IL-6) and growth factors (e.g., EGF, TGF-α), which stimulate mucosal cell proliferation. This can result in hyperplasia and the formation of hyperplastic polyps. Over time, acquired genetic mutations in oncogenes (e.g., K-ras) and tumor suppressor genes (e.g., APC, p53) can lead to adenomatous transformation. Adenomatous polyps are characterized by dysplasia, which is a precursor to adenocarcinoma. The progression from normal mucosa to hyperplastic polyp to adenoma to carcinoma is a well-established sequence in humans and is likely similar in animals. Macroscopically, polyps may be pedunculated (attached by a stalk) or sessile (flat-based). Histologically, they are composed of neoplastic epithelial cells with varying degrees of dysplasia. Inflammatory polyps are composed of granulation tissue and inflammatory cells, often secondary to chronic colitis. The clinical signs (tenesmus, hematochezia) result from mechanical obstruction, mucosal irritation, and ulceration.

Predisposing factors for rectal polyps include chronic inflammatory conditions of the colon and rectum, such as inflammatory bowel disease (IBD), lymphocytic-plasmacytic colitis, and histiocytic ulcerative colitis (especially in Boxers). Parasitic infections, particularly Trichuris vulpis (whipworm), can cause chronic mucosal irritation. Dietary factors, such as low-fiber diets, may reduce fecal bulk and increase transit time, allowing prolonged exposure of the mucosa to potential carcinogens. Genetic predisposition is significant, as certain breeds (Boxers, Collies, German Shepherds) have a higher incidence. Age is a major risk factor, with older animals being more susceptible. Immunosuppression, whether due to disease or medication, may increase the risk of viral-induced papillomas. Additionally, exposure to environmental carcinogens, such as tobacco smoke or pesticides, may contribute. Obesity and sedentary lifestyle have been suggested as risk factors in humans and may also apply to pets.

Clinical signs of rectal polyps are primarily related to the lower gastrointestinal tract. The most common signs include tenesmus (straining to defecate), hematochezia (fresh blood in feces), and dyschezia (painful defecation). Owners may report increased frequency of defecation, passage of small amounts of feces, and mucus in the stool. In some cases, the polyp may prolapse through the anus, appearing as a red, fleshy mass. Systemic signs are usually absent unless the polyp is malignant or there is significant blood loss. Chronic blood loss can lead to anemia, weakness, and weight loss. Cats may present with similar signs, but they are often more subtle, such as constipation or decreased appetite. Physical examination may reveal a palpable mass on digital rectal examination, which is essential in any animal with these signs. The mass may be smooth or irregular, and its size and location should be noted. Abdominal palpation may be unremarkable unless there is concurrent colonic involvement.

Differential diagnoses for rectal polyps include: 1. **Colorectal Adenocarcinoma**: Malignant tumor that can appear as a mass, often with irregular borders, ulceration, and infiltration. Histopathology is definitive; adenocarcinomas show invasive growth and cellular atypia. 2. **Lymphoma**: Can present as a mass or diffuse thickening of the rectal wall. Cytology/histopathology shows lymphocytic infiltration; immunophenotyping (B-cell vs T-cell) is helpful. 3. **Inflammatory Bowel Disease (IBD)**: Chronic inflammation may cause mucosal thickening and pseudopolyps. Biopsy shows inflammatory infiltrate without neoplastic changes. 4. **Chronic Colitis (e.g., lymphocytic-plasmacytic)**: Causes similar clinical signs; colonoscopy and biopsy are needed to differentiate. 5. **Rectal Foreign Body**: May cause tenesmus and hematochezia; imaging or endoscopy can identify. 6. **Rectal Prolapse**: Complete or partial prolapse of the rectum can mimic a polyp; physical examination and reduction attempt are diagnostic. 7. **Leiomyoma/Leiomyosarcoma**: Smooth muscle tumors arising from the muscularis; histopathology with immunohistochemistry (smooth muscle actin) is diagnostic. 8. **Granulomatous Colitis**: Especially in Boxers, can cause mass-like lesions; histopathology shows granulomatous inflammation. 9. **Parasitic Infection (e.g., whipworms)**: Can cause mucosal irritation and hematochezia; fecal flotation and response to anthelmintics are diagnostic. 10. **Anal Sac Disease**: Impacted or infected anal sacs can cause perianal swelling and tenesmus; digital palpation and expression are diagnostic.

The diagnostic approach to a suspected rectal polyp should be systematic: 1. **History and Physical Examination**: Obtain a thorough history, including duration of signs, diet, and any previous treatments. Perform a complete physical examination, with special attention to digital rectal examination. This is the first step and may reveal a mass. 2. **Fecal Examination**: Perform fecal flotation and direct smear to rule out parasitic infections (e.g., Trichuris vulpis). Also, check for occult blood. 3. **Laboratory Tests**: Complete blood count (CBC), serum biochemistry, and urinalysis to assess overall health and rule out systemic disease. Anemia may indicate chronic blood loss. 4. **Abdominal Imaging**: Abdominal radiographs may be normal but can show a soft tissue mass or obstruction. Abdominal ultrasound is more sensitive for detecting colorectal masses and assessing wall thickness and lymphadenopathy. 5. **Colonoscopy**: This is the gold standard for visualizing the rectal and colonic mucosa. It allows direct visualization of the polyp, assessment of its size, number, and location, and biopsy collection. Polyps can be removed via snare polypectomy during colonoscopy. 6. **Biopsy and Histopathology**: Biopsy samples should be obtained from the polyp and surrounding mucosa. Histopathology is essential for definitive diagnosis and to differentiate benign from malignant lesions. 7. **Advanced Imaging (CT/MRI)**: If malignancy is suspected or if the polyp is large and invasive, computed tomography (CT) or magnetic resonance imaging (MRI) may be used to assess local invasion and metastasis. 8. **Staging**: If adenocarcinoma is diagnosed, staging (thoracic radiographs, abdominal ultrasound, lymph node aspiration) is recommended to detect metastasis.

Laboratory findings in animals with rectal polyps are often unremarkable unless there is significant blood loss or concurrent disease. On complete blood count (CBC), chronic blood loss may result in microcytic, hypochromic anemia (low hemoglobin, low MCV, low MCHC). In acute hemorrhage, there may be a regenerative response with reticulocytosis. White blood cell count may be normal or elevated if there is inflammation. Serum biochemistry is typically normal, but in cases of chronic diarrhea, electrolyte imbalances (e.g., hypokalemia, hyponatremia) may be present. Total protein and albumin may be decreased if there is protein-losing enteropathy. Fecal occult blood test is often positive. Fecal flotation may reveal parasite eggs (e.g., Trichuris vulpis). In cases of inflammatory bowel disease, serum cobalamin (B12) and folate levels may be abnormal. Specific biomarkers such as C-reactive protein (CRP) may be elevated in inflammatory conditions. If lymphoma is suspected, lactate dehydrogenase (LDH) may be elevated. Urinalysis is usually normal.

Imaging findings for rectal polyps: - **Radiography**: Abdominal radiographs are often unremarkable. In some cases, a soft tissue mass may be visible in the pelvic canal, but this is rare. Contrast studies (barium enema) can outline the polyp but are rarely performed due to the availability of endoscopy. - **Ultrasonography**: Transabdominal ultrasound may show a focal mass in the rectal wall, with thickening of the muscularis and submucosa. The mass may appear as a hypoechoic or mixed echogenic lesion. Color Doppler may show increased vascularity. Ultrasound is also useful for assessing regional lymph nodes for metastasis. - **Computed Tomography (CT)**: CT provides excellent anatomical detail and is useful for evaluating the extent of the mass, invasion into surrounding tissues, and lymph node involvement. It is particularly helpful for surgical planning. - **Magnetic Resonance Imaging (MRI)**: MRI offers superior soft tissue contrast and is useful for assessing the layers of the rectal wall and any perirectal involvement. - **Endoscopy**: Colonoscopy is the primary imaging modality for rectal polyps. It allows direct visualization of the polyp, its size, shape, and location. Polyps appear as raised, pedunculated or sessile masses, often with a reddish or pinkish color. Endoscopic ultrasound (EUS) can be used to assess the depth of invasion.

Cytology and histopathology are crucial for definitive diagnosis. - **Cytology**: Fine-needle aspiration (FNA) of a rectal polyp can be performed, but it is often non-diagnostic due to the cohesive nature of epithelial cells. If obtained, cytology may show clusters of epithelial cells with varying degrees of dysplasia. Inflammatory polyps may show mixed inflammatory cells. - **Histopathology**: Biopsy is the gold standard. Histological features of an adenomatous polyp include: - Tubular, villous, or tubulovillous architecture. - Dysplastic epithelial cells with nuclear hyperchromasia, increased nuclear-to-cytoplasmic ratio, and loss of goblet cells. - Intact basement membrane (non-invasive). - Inflammatory polyps show granulation tissue, fibrosis, and inflammatory infiltrate (lymphocytes, plasma cells, neutrophils). - Special stains: Immunohistochemistry for Ki-67 (proliferation marker) and p53 may be used to assess malignant potential. Mucin stains (e.g., Alcian blue) can help differentiate adenomatous from hyperplastic polyps.

Treatment of rectal polyps depends on the size, number, and histopathological type. - **Surgical Excision**: For solitary, pedunculated polyps, surgical removal via transanal resection or rectal pull-through may be performed. For sessile or multiple polyps, a more extensive resection (e.g., partial proctectomy) may be necessary. - **Endoscopic Polypectomy**: During colonoscopy, polyps can be removed using a snare and electrocautery. This is minimally invasive and preferred for pedunculated polyps. - **Medical Management**: If the polyp is inflammatory, treating the underlying cause (e.g., IBD, parasites) may lead to regression. This includes: - Anthelmintics: Fenbendazole (50 mg/kg PO q24h for 3-5 days) for whipworms. - Anti-inflammatory drugs: Sulfasalazine (20-30 mg/kg PO q8h) or mesalamine (10-20 mg/kg PO q12h) for IBD. - Immunosuppressants: Prednisone (1-2 mg/kg PO q24h) or budesonide (2-3 mg/m² PO q24h) for severe IBD. - Dietary modification: High-fiber diet or hypoallergenic diet. - **Chemotherapy**: If the polyp is malignant (adenocarcinoma), surgical excision is the primary treatment, but adjunctive chemotherapy (e.g., doxorubicin, carboplatin) may be considered. - **Supportive Care**: For tenesmus and pain, analgesics such as tramadol (2-5 mg/kg PO q8-12h) or NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) may be used. Stool softeners (e.g., lactulose 0.5-1 mL/kg PO q8-12h) can ease defecation.

The prognosis for benign rectal polyps is excellent after complete surgical or endoscopic removal. Recurrence is possible, especially if the underlying inflammatory condition is not controlled. For adenomatous polyps with high-grade dysplasia, there is a risk of malignant transformation, so regular monitoring is recommended. The prognosis for malignant adenocarcinoma is guarded to poor, depending on the stage and completeness of excision. Five-year survival rates for canine colorectal adenocarcinoma are low, with median survival times of 6-12 months with surgery alone. Negative prognostic factors include large tumor size, invasion into the muscularis, lymph node metastasis, and high histologic grade. Early detection and treatment improve outcomes.

Follow-up is essential to monitor for recurrence and malignant transformation. - **Re-check Examinations**: Perform a digital rectal examination every 3-6 months for the first year after treatment. - **Colonoscopy**: Repeat colonoscopy every 6-12 months for the first 2 years, then annually if no recurrence. - **Fecal Occult Blood Test**: Perform every 3-6 months to detect early bleeding. - **Laboratory Monitoring**: CBC and biochemistry every 6-12 months to assess for anemia or systemic effects. - **Imaging**: Abdominal ultrasound every 6-12 months to evaluate for local recurrence or metastasis. - **Diet and Lifestyle**: Maintain a high-fiber diet and regular exercise to promote gastrointestinal health. - **Owner Education**: Instruct owners to monitor for signs of tenesmus, hematochezia, or changes in defecation habits and report immediately.

**Pearls:** - Always perform a digital rectal examination in any dog or cat with tenesmus or hematochezia; it is a simple, cost-effective diagnostic tool. - Colonoscopy with biopsy is essential for definitive diagnosis; do not rely on cytology alone. - Inflammatory polyps may regress with treatment of the underlying cause, so always investigate for IBD and parasites. - For pedunculated polyps, endoscopic polypectomy is preferred due to lower morbidity. - Consider the possibility of multiple polyps; perform a full colonoscopy, not just a rectal exam.

**Pitfalls:** - Mistaking a polyp for a malignant tumor without histopathology can lead to unnecessary aggressive surgery. - Failing to biopsy the surrounding mucosa may miss concurrent inflammatory bowel disease. - Overlooking parasitic infections (e.g., whipworms) can lead to recurrence. - Incomplete excision of a sessile polyp may result in recurrence or malignant transformation. - Not staging a malignant tumor can lead to missed metastasis and poor prognosis.

Based on Plumb's Veterinary Drug Handbook, the following drug protocols may be used: - **Anthelmintics**: Fenbendazole (Panacur) 50 mg/kg PO q24h for 3-5 days; repeat in 3 weeks for whipworms. - **Anti-inflammatory/Immunosuppressive**: - Sulfasalazine (Azulfidine) 20-30 mg/kg PO q8h (max 3 g/day) for IBD; monitor for keratoconjunctivitis sicca. - Mesalamine (Pentasa) 10-20 mg/kg PO q12h. - Prednisone 1-2 mg/kg PO q24h, tapering over weeks. - Budesonide (Entocort) 2-3 mg/m² PO q24h for IBD. - **Analgesics**: - Tramadol 2-5 mg/kg PO q8-12h. - Carprofen (Rimadyl) 2.2 mg/kg PO q12h (max 4.4 mg/kg/day) for pain/inflammation. - **Stool Softeners**: Lactulose 0.5-1 mL/kg PO q8-12h. - **Antibiotics (if secondary infection)**: Metronidazole 10-15 mg/kg PO q12h for 7-10 days. - **Chemotherapy (for adenocarcinoma)**: Doxorubicin 30 mg/m² IV q3 weeks; Carboplatin 300 mg/m² IV q3 weeks. Adjust doses based on renal/hepatic function and CBC. - **Supportive**: Fluid therapy with balanced electrolytes (e.g., Lactated Ringer's) for dehydration.

Always consider contraindications: NSAIDs should be avoided in patients with renal disease, gastrointestinal ulceration, or bleeding disorders. Corticosteroids may exacerbate infections. Dosage adjustments are needed in hepatic or renal impairment.

Evidence-based literature on rectal polyps in veterinary medicine is limited but growing. A retrospective study by Valerius et al. (1997) evaluated 45 dogs with colorectal polyps and found that adenomatous polyps were the most common, with a recurrence rate of 10% after surgical excision. Another study by Church et al. (2003) reported that endoscopic polypectomy is a safe and effective treatment for pedunculated polyps in dogs. A consensus statement from the ACVIM on canine chronic inflammatory enteropathy (2010) emphasizes the importance of biopsy to differentiate inflammatory polyps from neoplastic ones. In terms of malignant transformation, a study by Patnaik et al. (1980) described the progression from adenoma to carcinoma in dogs, highlighting the need for early removal. More recent studies have investigated the role of COX-2 inhibitors in preventing colorectal cancer in dogs, but results are inconclusive. Overall, the literature supports surgical or endoscopic excision as the standard of care, with histopathology guiding prognosis. Regular follow-up is recommended to detect recurrence.